|
Universal flu vaccine trials show promise |
 |
 |
|
EurekAlert: Unlike traditional flu vaccines, which target antigens that change continuously, the prototype VAX102 represents a vaccine that would not require annual updates, an important barrier to influenza prevention throughout the world. The technology used to produce the candidate vaccine would eliminate many of the limitations of current influenza vaccines, including inefficiencies related to manufacturing – such as limited production capability and the inability to change the target antigen should the vaccine not match the circulating strains.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
